Davarpanah Nicole Negar 4
4 · Cidara Therapeutics, Inc. · Filed May 12, 2025
Insider Transaction Report
Form 4
Davarpanah Nicole Negar
Chief Medical Officer
Transactions
- Award
Common Stock
2025-05-01+10,000→ 31,692 total - Award
Employee Stock Option (right to buy)
2025-05-01+20,000→ 20,000 totalExercise: $21.75Exp: 2035-04-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on May 1, 2025. All RSUs vest in three equal annual installments, with 1/3 vesting on each of June 10, 2026, 2027, and 2028, subject to continuous service through each such Vesting Date.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of May 1, 2025, subject to continuous service through each such Vesting Date.